Analysts anticipate Bio-Techne to report an earnings per share (EPS) of $0.40.
Investors in Bio-Techne are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Historical Earnings Performance
In the previous earnings release, the company beat EPS by $0.05, leading to a 0.56% increase in the share price the following trading session.
Here's a look at Bio-Techne's past performance and the resulting price change:
Quarter
Q4 2025
Q3 2025
Q2 2025
Q1 2025
EPS Estimate
0.48
0.51
0.38
0.38
EPS Actual
0.53
0.56
0.42
0.42
Price Change %
1.00
2.00
0.00
-3.00
Tracking Bio-Techne's Stock Performance
Shares of Bio-Techne were trading at $61.26 as of November 03. Over the last 52-week period, shares are down 17.88%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
Analysts' Take on Bio-Techne
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Bio-Techne.
A total of 5 analyst ratings have been received for Bio-Techne, with the consensus rating being Buy. The ...